Covestor LTD Insmed Inc Transaction History

Covestor LTD

$157 Million
Q1 2024

A detailed history of Covestor LTD transactions in Insmed Inc stock. As of the latest transaction made, Covestor LTD holds 7 shares of INSM stock, worth $490. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 7 -0.0%

Holding current value

$490

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$23.42 - $31.74 $23 - $31	-1 Reduced 12.5%	7 $0
Q3 2023 Nov 13, 2023	SELL	$19.86 - $26.93 $3,237 - $4,389	-163 Reduced 95.32%	8 $0
Q2 2023 Aug 11, 2023	SELL	$16.44 - $21.1 $10,275 - $13,187	-625 Reduced 78.52%	171 $4,000
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $12,796 - $17,101	787 Added 8744.44%	796 $14,000
Q4 2022 Feb 13, 2023	SELL	$16.98 - $23.15 $16 - $23	-1 Reduced 10.0%	9 $0

Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $104 - $141	-5 Reduced 33.33%	10 $0
Q2 2022 Aug 10, 2022	SELL	$17.07 - $25.71 $68 - $102	-4 Reduced 21.05%	15 $0
Q1 2022 May 13, 2022	SELL	$20.42 - $28.13 $102 - $140	-5 Reduced 20.83%	19 $0
Q4 2021 Feb 10, 2022	BUY	$25.89 - $33.45 $621 - $802	24 New	24 $1,000

Others Institutions Holding INSM

# of Institutions

340

Shares Held

141M

Call Options Held

2.25M

Put Options Held

3.11M

Vanguard Group Inc Valley Forge, PA

14.5M
Shares

$1.02 Billion
0.01% of portfolio
Black Rock Inc. New York, NY

11.8M
Shares

$826 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

10.8M
Shares

$754 Million
0.04% of portfolio
State Street Corp Boston, MA

5.91M
Shares

$413 Million
0.01% of portfolio
Deep Track Capital, LP Greenwich, CT

4.78M
Shares

$335 Million
4.29% of portfolio

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.48B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account